These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8556141)

  • 1. Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonia-lyase: a preliminary report.
    Safos S; Chang TM
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(6):681-92. PubMed ID: 8556141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN; Gámez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-based chemical modification strategy for enzyme replacement treatment of phenylketonuria.
    Wang L; Gamez A; Sarkissian CN; Straub M; Patch MG; Han GW; Striepeke S; Fitzpatrick P; Scriver CR; Stevens RC
    Mol Genet Metab; 2005; 86(1-2):134-40. PubMed ID: 16006165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte-mediated delivery of phenylalanine ammonia lyase for the treatment of phenylketonuria in BTBR-Pah(enu2) mice.
    Rossi L; Pierigè F; Carducci C; Gabucci C; Pascucci T; Canonico B; Bell SM; Fitzpatrick PA; Leuzzi V; Magnani M
    J Control Release; 2014 Nov; 194():37-44. PubMed ID: 25151978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of pegylated forms of recombinant Rhodosporidium toruloides phenylalanine ammonia-lyase for the treatment of classical phenylketonuria.
    Gámez A; Sarkissian CN; Wang L; Kim W; Straub M; Patch MG; Chen L; Striepeke S; Fitzpatrick P; Lemontt JF; O'Neill C; Scriver CR; Stevens RC
    Mol Ther; 2005 Jun; 11(6):986-9. PubMed ID: 15922970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylalanine ammonia-lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria.
    Ikeda K; Schiltz E; Fujii T; Takahashi M; Mitsui K; Kodera Y; Matsushima A; Inada Y; Schulz GE; Nishimura H
    Amino Acids; 2005 Nov; 29(3):283-7. PubMed ID: 15977040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenylalanine ammonia-lyase immobilized in microcapsules for the depletion of phenylalanine in plasma in phenylketonuric rat model.
    Bourget L; Chang TM
    Biochim Biophys Acta; 1986 Oct; 883(3):432-8. PubMed ID: 3756210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria.
    Gámez A; Wang L; Sarkissian CN; Wendt D; Fitzpatrick P; Lemontt JF; Scriver CR; Stevens RC
    Mol Genet Metab; 2007 Aug; 91(4):325-34. PubMed ID: 17560821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new theory of enterorecirculation of amino acids and its use for depleting unwanted amino acids using oral enzyme-artificial cells, as in removing phenylalanine in phenylketonuria.
    Chang TM; Bourget L; Lister C
    Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(1):1-21. PubMed ID: 7719440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral administration of artificial cells immobilized phenylalanine ammonia-lyase on intestinal amino acids of phenylketonuric rats.
    Bourget L; Chang TM
    Biomater Artif Cells Artif Organs; 1989; 17(2):161-81. PubMed ID: 2775877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial rescue of neuropathology in the murine model of PKU following administration of recombinant phenylalanine ammonia lyase (pegvaliase).
    Goldfinger M; Zeile WL; Corado CR; O'Neill CA; Tsuruda LS; Laipis PJ; Cooper JD
    Mol Genet Metab; 2017 Sep; 122(1-2):33-35. PubMed ID: 28506393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of phenylalanine in the blood of phenylketonuric patients using a PAL-enzyme reactor. An in vitro study.
    Ambrus CM; Horváth C; Kalghatgi K; Clowsley M; Huzella C; Warner R; Ambrus JL; Cooley CM; Mirand EA
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):105-11. PubMed ID: 7122995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservation of high phenylalanine ammonia lyase activities in roots of Japanese Striped corn: a potential oral therapeutic to treat phenylketonuria.
    López-Villalobos A; Lücker J; López-Quiróz AA; Yeung EC; Palma K; Kermode AR
    Cryobiology; 2014 Jun; 68(3):436-45. PubMed ID: 24657198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylalanine ammonia-lyase immobilized in semipermeable microcapsules for enzyme replacement in phenylketonuria.
    Bourget L; Chang TM
    FEBS Lett; 1985 Jan; 180(1):5-8. PubMed ID: 4038490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and PEGylation optimization of the therapeutic PEGylated phenylalanine ammonia lyase for the treatment of phenylketonuria.
    Bell SM; Wendt DJ; Zhang Y; Taylor TW; Long S; Tsuruda L; Zhao B; Laipis P; Fitzpatrick PA
    PLoS One; 2017; 12(3):e0173269. PubMed ID: 28282402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of Phenylketonuria.
    Sarkissian CN; Kang TS; Gámez A; Scriver CR; Stevens RC
    Mol Genet Metab; 2011 Nov; 104(3):249-54. PubMed ID: 21803624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical properties and immunogenicity of L-phenylalanine ammonia-lyase: effects on tumor-bearing mice.
    Shen RS; Fritz RR; Abell CW
    Cancer Treat Rep; 1979 Jun; 63(6):1063-8. PubMed ID: 466645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo safety of hollow fiber enzyme-reactors with immobilized phenylalanine ammonia-lyase in a large animal model for phenylketonuria.
    Ambrus CM; Sharma SD; Horváth C; Kalghatgi K; Anthone S; Ambrus JL; Cooley C; Mirand EA
    J Pharmacol Exp Ther; 1983 Mar; 224(3):598-602. PubMed ID: 6681841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of multiple species of PEGylated recombinant phenylalanine ammonia lyase for the treatment of phenylketonuria.
    Sarkissian CN; Gámez A; Wang L; Charbonneau M; Fitzpatrick P; Lemontt JF; Zhao B; Vellard M; Bell SM; Henschell C; Lambert A; Tsuruda L; Stevens RC; Scriver CR
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20894-9. PubMed ID: 19095795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegvaliase for the treatment of phenylketonuria: Results of the phase 2 dose-finding studies with long-term follow-up.
    Burton BK; Longo N; Vockley J; Grange DK; Harding CO; Decker C; Li M; Lau K; Rosen O; Larimore K; Thomas J;
    Mol Genet Metab; 2020 Aug; 130(4):239-246. PubMed ID: 32593547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.